Received: 27 July 2021
Accepted: 13 May 2022
First Online: 2 June 2022
: Ethics approval was obtained from Centre for Chronic Disease Control’s Institutional ethics committee. Ethics approval number was IRB00006330288 dated 05/10/2018. Study was carried out in accordance with ethical guidelines of Centre for Chronic Disease Control institute. Informed consent was obtained from all the participants.
: Not applicable.
: The authors declare no competing interest.